ProMIS Neurosciences annual r&d spending
2021
2022
2023
2024
2025
ProMIS Neurosciences R&D Spending Growth & History (PMN)
ProMIS Neurosciences's r&d spending was $33.4M for fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $33.4M | $22.7M | +213.78% |
| 2024 | 2024-12-31 | $10.6M | $2.8M | +34.95% |
| 2023 | 2023-12-31 | $7.9M | −$8.2M | −51.00% |
| 2022 | 2022-12-31 | $16.1M | $11.5M | +247.65% |
| 2021 | 2021-12-31 | $4.6M | — | — |
ProMIS Neurosciences quarterly r&d spending
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.5M | $772,009 | +8.82% |
| Q1 2026 | 2026-03-31 | $7.0M | $1.5M | +27.57% |
| Q4 2025 | 2025-12-31 | $9.4M | $5.0M | +116.62% |
| Q3 2025 | 2025-09-30 | $9.8M | $7.2M | +282.15% |
| Q2 2025 | 2025-06-30 | $8.7M | $7.1M | +438.18% |
| Q1 2025 | 2025-03-31 | $5.5M | $3.3M | +157.29% |
| Q4 2024 | 2024-12-31 | $4.3M | $2.1M | +94.36% |
| Q3 2024 | 2024-09-30 | $2.6M | $1.4M | +124.47% |
| Q2 2024 | 2024-06-30 | $1.6M | $620,106 | +61.66% |
| Q1 2024 | 2024-03-31 | $2.1M | −$1.4M | −39.50% |
| Q4 2023 | 2023-12-31 | $2.2M | −$4.2M | −65.15% |
| Q3 2023 | 2023-09-30 | $1.1M | −$3.4M | −75.01% |
| Q2 2023 | 2023-06-30 | $1.0M | −$2.2M | −68.86% |
| Q1 2023 | 2023-03-31 | $3.5M | $1.6M | +84.48% |
| Q4 2022 | 2022-12-31 | $6.4M | — | — |
| Q3 2022 | 2022-09-30 | $4.6M | $3.8M | +467.50% |
| Q2 2022 | 2022-06-30 | $3.2M | $2.5M | +328.16% |
| Q1 2022 | 2022-03-31 | $1.9M | — | — |
| Q3 2021 | 2021-09-30 | $805,392 | — | — |
| Q2 2021 | 2021-06-30 | $754,302 | — | — |
ProMIS Neurosciences r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, ProMIS Neurosciences's r&d spending increased from $4.6M to $33.4M, a change of $28.8M. The latest reported quarter, Q2 2026, shows $9.5M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences source filings ↗